A cutting-edge pharmaceutical company with a new drug to treat obesity wanted a white paper  to explore the benefits of pharmacotherapy for obese patients, and specifically how employers could afford it to purchase the drug for their highest risk employees. Elizabeth combed through all the data on the drug and interviewed company executives to get to a more employer-friendly piece.

CLICK HERE to view white paper.